Bayer Unloads Diabetes Devices; Panasonic Healthcare Expands Reach
This article was originally published in The Gray Sheet
Executive Summary
After years of rumors that it wanted to get out of the diabetes care business, Bayer announced a $1.15 billion sale of that unit to Panasonic Healthcare Holdings, another step away from the medical device market.